 BEDMER, N.J.--BUSINESS WIRE--Tyme Technologies, Inc. NASDAQ: TYME, an emerging biotechnology company developing cancer metabolism-based therapies CMBTsTM, announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Companys metabolomic technology platform. The patent, U.S. Patent No. 11,058,638, involves a targeted delivery of therapeutics to cancer cells. Tyme has developed a technology by which th 